NovaBridge Biosciences - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US44975P1030
1,48 € ↑0,02 (1,37%)
2026-06-04
DEL PRIS
SecurityDE:0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership57,489 shares
Latest Disclosed Value $ 128,775
Jpmorgan Chase & Co reports 56.39% decrease in ownership of 0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 57,489 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock) (DE:0VY) valued at $110,954 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 131,830 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock). This represents a change in shares of -56.39% during the quarter. The current value of the position is $85,084 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 NOVABRIDGE BIOSCIENCES ADR 44975P103 57,489 -74,341 -56.39 129 -75.57 0.0000
2026-02-11 2025-12-31 13F NOVABRIDGE BIOSCIENCES ADR 44975P103 131,830 -18,334 -12.21 525 -7.58 0.0000
2025-11-26 2025-09-30 13F/A-1 I MAB ADR 44975P103 150,164 150,164 568 0.0000
2025-11-07 2025-09-30 13F I MAB ADR 44975P103 150,164 150,164 568 0.0000
2025-08-12 2025-06-30 13F I MAB ADR 44975P103 0 -5,000 -100.00 0 -100.00
2025-05-12 2025-03-31 13F I MAB ADR 44975P103 5,000 5,000 4 0.0000
2024-12-26 2023-12-31 13F/A-1 I MAB ADR 44975P103 0 -477,895 -100.00 0 -100.00
2024-02-12 2023-12-31 13F I MAB ADR 44975P103 0 0
2023-11-14 2023-09-30 13F I MAB ADR 44975P103 477,895 -119,479 -20.00 631 -64.73 0.0001
2023-08-11 2023-06-30 13F I MAB ADR 44975P103 597,374 37,079 6.62 1,786 -7.89 0.0002
2023-05-18 2023-03-31 13F/A-1 I MAB ADR 44975P103 560,295 -217,250 -27.94 1,939 64,533.33 0.0002
2023-05-11 2023-03-31 13F I MAB ADR 44975P103 560,295 -217,250 1,939 0.0000
2023-02-13 2022-12-31 13F I MAB ADR 44975P103 777,545 771,682 13,161.90 3 -87.50 0.0004
2022-11-14 2022-09-30 13F I MAB ADR 44975P103 5,863 -243,109 -97.65 24 -99.15 0.0000
2022-08-11 2022-06-30 13F I MAB ADR 44975P103 248,972 132,835 114.38 2,813 49.15 0.0004
2022-05-11 2022-03-31 13F I MAB ADR 44975P103 116,137 113,787 4,842.00 1,886 1,599.10 0.0002
2022-02-11 2021-12-31 13F/A-1 I MAB ADR 44975P103 2,350 -23,940 -91.06 111 -94.17 0.0000
2022-02-10 2021-12-31 13F I MAB ADR 44975P103 2,350 -23,940 111 0.0000
2021-11-12 2021-09-30 13F I MAB ADR 44975P103 26,290 -124,008 -82.51 1,905 -84.90 0.0002
2021-08-12 2021-06-30 13F I MAB ADR 44975P103 150,298 7,075 4.94 12,618 81.76 0.0015
2021-05-12 2021-03-31 13F I MAB ADR 44975P103 143,223 143,211 1,193,425.00 6,942 694,100.00 0.0009
2021-02-19 2020-12-31 13F/A-1 I MAB ADR 44975P103 12 -6,049 -99.80 1 -99.57 0.0000
2021-02-11 2020-12-31 13F I MAB ADR 44975P103 12 -6,049 1 0.0247
2020-11-12 2020-09-30 13F/A-1 I MAB ADR 44975P103 6,061 5,914 4,023.13 233 5,725.00 0.0000
2020-11-12 2020-09-30 13F I MAB ADR 44975P103 6,061 233
2020-08-11 2020-06-30 13F I MAB ADR 44975P103 147 147 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.